BlackRock Fund Advisors’s Meridian Bioscience Inc VIVO Stock Holding History

BlackRock Fund Advisors’s Portfolio VIVO Stock Details VIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$58.7M	Buy	3,316,619 +441,341	+15%	+$7.75M	0.01%	1577
2016 Q3	$55.5M	Buy	2,875,278 +202,185	+8%	+$3.96M	0.01%	1500
2016 Q2	$52.1M	Buy	2,673,093 +71,126	+3%	+$1.39M	0.01%	1461
2016 Q1	$53.6M	Sell	2,601,967 -13,851	-0.5%	-$273K	0.01%	1414
2015 Q4	$53.7M	Buy	2,615,818 +144,283	+6%	+$2.77M	0.01%	1424
2015 Q3	$42.3M	Buy	2,471,535 +63,275	+3%	+$1.16M	0.01%	1526
2015 Q2	$44.9M	Sell	2,408,260 -34,396	-1%	-$638K	0.01%	1597
2015 Q1	$46.6M	Buy	2,442,656 +132,728	+6%	+$2.45M	0.01%	1550
2014 Q4	$38M	Buy	2,309,928 +231,542	+11%	+$3.97M	0.01%	1655
2014 Q3	$36.8M	Sell	2,078,386 -32,020	-2%	-$629K	0.01%	1557
2014 Q2	$43.6M	Sell	2,110,406 -162,428	-7%	-$3.34M	0.01%	1483
2014 Q1	$49.5M	Buy	2,272,834 +29,852	+1%	+$684K	0.01%	1421
2013 Q4	$59.5M	Buy	2,242,982 +43,262	+2%	+$1.06M	0.02%	1272
2013 Q3	$52M	Buy	2,199,720 +222,588	+11%	+$5.2M	0.02%	1308
2013 Q2	$42.5M	Buy	+1,977,132	New	+$42.6M	0.02%	1344

Other funds holding VIVO

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return

BTW

Boston Trust Walden Boston, Massachusetts $12.2B AUM 12.45% 1-Year Est. Return

BlackRock Fund Advisors's VIVO Position: Q4 2016 in Review

BlackRock Fund Advisors increased its Meridian Bioscience Inc (VIVO) stake by 15% in Q4 2016, buying an estimated $7.75M and bringing the position to 3,316,619 shares worth $58.7M. The position accounts for 0.01% of the portfolio, ranked #1577.

BlackRock Fund Advisors first reported a position in VIVO in Q2 2013 and has held it in 15 quarters since. The position peaked at $59.5M in Q4 2013. 180 funds tracked by Wall St. Rank hold VIVO as of Q4 2016.

BlackRock Fund Advisors held 3,316,619 shares of Meridian Bioscience Inc worth $58.7M as of Q4 2016.
BlackRock Fund Advisors bought 441,341 Meridian Bioscience Inc shares in Q4 2016, an estimated $7.75M.
Meridian Bioscience Inc made up 0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #1577 holding.
BlackRock Fund Advisors first reported a position in Meridian Bioscience Inc in Q2 2013 and has held it in 15 quarters since.
BlackRock Fund Advisors's Meridian Bioscience Inc position peaked at $59.5M in Q4 2013.
180 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.